Literature DB >> 23487407

Regulation of cardiac hypertrophic signaling by prolyl isomerase Pin1.

Haruhiro Toko1, Mathias H Konstandin, Shirin Doroudgar, Lucia Ormachea, Eri Joyo, Anya Y Joyo, Shabana Din, Natalie A Gude, Brett Collins, Mirko Völkers, Donna J Thuerauf, Christopher C Glembotski, Chun-Hau Chen, Kun Ping Lu, Oliver J Müller, Takafumi Uchida, Mark A Sussman.   

Abstract

RATIONALE: Cardiac hypertrophy results from the complex interplay of differentially regulated cascades based on the phosphorylation status of involved signaling molecules. Although numerous critical regulatory kinases and phosphatases have been identified in the myocardium, the intracellular mechanism for temporal regulation of signaling duration and intensity remains obscure. In the nonmyocyte context, control of folding, activity, and stability of proteins is mediated by the prolyl isomerase Pin1, but the role of Pin1 in the heart is unknown.
OBJECTIVE: To establish the role of Pin1 in the heart. METHODS AND
RESULTS: Here, we show that either genetic deletion or cardiac overexpression of Pin1 blunts hypertrophic responses induced by transaortic constriction and consequent cardiac failure in vivo. Mechanistically, we find that Pin1 directly binds to Akt, mitogen activated protein kinase (MEK), and Raf-1 in cultured cardiomyocytes after hypertrophic stimulation. Furthermore, loss of Pin1 leads to diminished hypertrophic signaling of Akt and MEK, whereas overexpression of Pin1 increases Raf-1 phosphorylation on the autoinhibitory site Ser259, leading to reduced MEK activation.
CONCLUSIONS: Collectively, these data support a role for Pin1 as a central modulator of the intensity and duration of 2 major hypertrophic signaling pathways, thereby providing a novel target for regulation and control of cardiac hypertrophy.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23487407      PMCID: PMC3742109          DOI: 10.1161/CIRCRESAHA.113.301084

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  49 in total

Review 1.  The prolyl isomerase PIN1: a pivotal new twist in phosphorylation signalling and disease.

Authors:  Kun Ping Lu; Xiao Zhen Zhou
Journal:  Nat Rev Mol Cell Biol       Date:  2007-11       Impact factor: 94.444

Review 2.  Prolyl cis-trans isomerization as a molecular timer.

Authors:  Kun Ping Lu; Greg Finn; Tae Ho Lee; Linda K Nicholson
Journal:  Nat Chem Biol       Date:  2007-10       Impact factor: 15.040

Review 3.  Role of the insulin-like growth factor 1 (IGF1)/phosphoinositide-3-kinase (PI3K) pathway mediating physiological cardiac hypertrophy.

Authors:  Julie R McMullen; Seigo Izumo
Journal:  Novartis Found Symp       Date:  2006

4.  Preservation of myocardial structure is enhanced by pim-1 engineering of bone marrow cells.

Authors:  Pearl Quijada; Haruhiro Toko; Kimberlee M Fischer; Brandi Bailey; Patrick Reilly; Kristin D Hunt; Natalie A Gude; Daniele Avitabile; Mark A Sussman
Journal:  Circ Res       Date:  2012-05-22       Impact factor: 17.367

5.  The prolyl isomerase Pin1 enhances HER-2 expression and cellular transformation via its interaction with mitogen-activated protein kinase/extracellular signal-regulated kinase kinase 1.

Authors:  Prem Khanal; Gwang Mo Namgoong; Bong Seok Kang; Eun-Rhan Woo; Hong Seok Choi
Journal:  Mol Cancer Ther       Date:  2010-02-23       Impact factor: 6.261

6.  Improved cardiac gene transfer by transcriptional and transductional targeting of adeno-associated viral vectors.

Authors:  Oliver J Müller; Barbara Leuchs; Sven T Pleger; Dirk Grimm; Wolfgang-M Franz; Hugo A Katus; Jürgen A Kleinschmidt
Journal:  Cardiovasc Res       Date:  2006-01-31       Impact factor: 10.787

7.  Mice lacking Pin1 develop normally, but are defective in entering cell cycle from G(0) arrest.

Authors:  F Fujimori; K Takahashi; C Uchida; T Uchida
Journal:  Biochem Biophys Res Commun       Date:  1999-11-30       Impact factor: 3.575

8.  Prevalent overexpression of prolyl isomerase Pin1 in human cancers.

Authors:  Lere Bao; Amy Kimzey; Guido Sauter; Janusz M Sowadski; Kun Ping Lu; Da-Gong Wang
Journal:  Am J Pathol       Date:  2004-05       Impact factor: 4.307

Review 9.  Pin1 as an anticancer drug target.

Authors:  Guoyan G Xu; Felicia A Etzkorn
Journal:  Drug News Perspect       Date:  2009-09

10.  Essential role of Pin1 in the regulation of TRF1 stability and telomere maintenance.

Authors:  Tae Ho Lee; Adrian Tun-Kyi; Rong Shi; Jormay Lim; Christina Soohoo; Greg Finn; Martin Balastik; Lucia Pastorino; Gerburg Wulf; Xiao Zhen Zhou; Kun Ping Lu
Journal:  Nat Cell Biol       Date:  2008-12-07       Impact factor: 28.824

View more
  17 in total

Review 1.  Recent Developments in Heart Failure.

Authors:  Sujith Dassanayaka; Steven P Jones
Journal:  Circ Res       Date:  2015-09-11       Impact factor: 17.367

2.  Manipulating PML SUMOylation via Silencing UBC9 and RNF4 Regulates Cardiac Fibrosis.

Authors:  Yu Liu; Dan Zhao; Fang Qiu; Ling-Ling Zhang; Shang-Kun Liu; Yuan-Yuan Li; Mei-Tong Liu; Di Wu; Jia-Xin Wang; Xiao-Qing Ding; Yan-Xin Liu; Chang-Jiang Dong; Xiao-Qi Shao; Bao-Feng Yang; Wen-Feng Chu
Journal:  Mol Ther       Date:  2017-01-28       Impact factor: 11.454

3.  Differential regulation of cellular senescence and differentiation by prolyl isomerase Pin1 in cardiac progenitor cells.

Authors:  Haruhiro Toko; Nirmala Hariharan; Mathias H Konstandin; Lucia Ormachea; Michael McGregor; Natalie A Gude; Balaji Sundararaman; Eri Joyo; Anya Y Joyo; Brett Collins; Shabana Din; Sadia Mohsin; Takafumi Uchida; Mark A Sussman
Journal:  J Biol Chem       Date:  2013-12-27       Impact factor: 5.157

4.  ATR Plays a Direct Antiapoptotic Role at Mitochondria, which Is Regulated by Prolyl Isomerase Pin1.

Authors:  Benjamin A Hilton; Zhengke Li; Phillip R Musich; Hui Wang; Brian M Cartwright; Moises Serrano; Xiao Zhen Zhou; Kun Ping Lu; Yue Zou
Journal:  Mol Cell       Date:  2015-09-18       Impact factor: 17.970

Review 5.  Pin1: a molecular orchestrator in the heart.

Authors:  Nirmala Hariharan; Mark A Sussman
Journal:  Trends Cardiovasc Med       Date:  2014-06-04       Impact factor: 6.677

6.  PIN1 Protects Hair Cells and Auditory HEI-OC1 Cells against Senescence by Inhibiting the PI3K/Akt/mTOR Pathway.

Authors:  Yanzhuo Zhang; Zhe Lv; Yudong Liu; Huan Cao; Jianwang Yang; Baoshan Wang
Journal:  Oxid Med Cell Longev       Date:  2021-06-02       Impact factor: 6.543

Review 7.  A Review of the Molecular Mechanisms Underlying the Development and Progression of Cardiac Remodeling.

Authors:  Leonardo Schirone; Maurizio Forte; Silvia Palmerio; Derek Yee; Cristina Nocella; Francesco Angelini; Francesca Pagano; Sonia Schiavon; Antonella Bordin; Albino Carrizzo; Carmine Vecchione; Valentina Valenti; Isotta Chimenti; Elena De Falco; Sebastiano Sciarretta; Giacomo Frati
Journal:  Oxid Med Cell Longev       Date:  2017-07-02       Impact factor: 6.543

8.  The Essential Role of Pin1 via NF-κB Signaling in Vascular Inflammation and Atherosclerosis in ApoE-/- Mice.

Authors:  Ming Liu; Peng Yu; Hong Jiang; Xue Yang; Ji Zhao; Yunzeng Zou; Junbo Ge
Journal:  Int J Mol Sci       Date:  2017-03-16       Impact factor: 5.923

Review 9.  Physiological and Pathogenic Roles of Prolyl Isomerase Pin1 in Metabolic Regulations via Multiple Signal Transduction Pathway Modulations.

Authors:  Yusuke Nakatsu; Yasuka Matsunaga; Takeshi Yamamotoya; Koji Ueda; Yuki Inoue; Keiichi Mori; Hideyuki Sakoda; Midori Fujishiro; Hiraku Ono; Akifumi Kushiyama; Tomoichiro Asano
Journal:  Int J Mol Sci       Date:  2016-09-07       Impact factor: 5.923

10.  Peptidyl-Prolyl Isomerase 1 Regulates Ca2+ Handling by Modulating Sarco(Endo)Plasmic Reticulum Calcium ATPase and Na2+/Ca2+ Exchanger 1 Protein Levels and Function.

Authors:  Veronica Sacchi; Bingyan J Wang; Dieter Kubli; Alexander S Martinez; Jung-Kang Jin; Roberto Alvarez; Nirmala Hariharan; Christopher Glembotski; Takafumi Uchida; James S Malter; Yijun Yang; Polina Gross; Chen Zhang; Steven Houser; Marcello Rota; Mark A Sussman
Journal:  J Am Heart Assoc       Date:  2017-10-10       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.